Segment reporting (Details 2) ¥ in Millions, $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Dec. 31, 2024
CNY (¥)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
CNY (¥)
|
Dec. 31, 2022
CNY (¥)
|
|||
| Share-based compensation | ¥ (2,999) | ¥ (4,804) | ¥ (7,548) | |||
| Impairment of goodwill | (799) | $ (109) | (3,143) | 0 | ||
| Impairment of intangible assets | (535) | (902) | 0 | |||
| Total | 38,736 | $ 5,307 | 26,025 | 19,723 | ||
| Unallocated items | ||||||
| Share-based compensation | (2,999) | (4,804) | (7,548) | |||
| Amortization of intangible assets resulting from assets and business acquisitions | (1,010) | (1,281) | (1,217) | |||
| Effects of business cooperation arrangements | (450) | (446) | (475) | |||
| Impairment of goodwill | (799) | (3,143) | ||||
| Impairment of intangible assets | (535) | (902) | ||||
| Total | [1] | ¥ (5,793) | ¥ (10,576) | ¥ (9,240) | ||
| ||||||
| X | ||||||||||
- Definition Amortization of intangible assets resulting from assets and business acquisitions. No definition available.
|
| X | ||||||||||
- Definition Effects of business cooperation arrangements. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|